Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Recombinant human hepatocarcinoma-intestine-pancreas / pancreatic associated protein

EU orphan designation number: EU/3/08/611   
Active ingredient: Recombinant human hepatocarcinoma-intestine-pancreas / pancreatic associated protein
Indication: Treatment of acute liver failure
Sponsor: Alfact Innovation SAS
320 rue Saint Honoré, 75001 Paris, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
13/02/2009 Orphan designation EMEA/OD/085/08 (2009)1052 of 11/02/2009